Introduction
Because of its role in potentiating the action of insulin in clearing postprandial glucose from the blood, Cr is considered essential for normal carbohydrate metabolism in humans and a number of other nonruminants (Anderson, 1987; Mertz, 1993) . Ruminants derive most of their glucose requirements from hepatic gluconeogenesis rather than from intestinal absorption, and their tissues seem to be more refractory to insulin than the tissues of nonruminants (Brockman, 1986) . As such, the effect of a Cr deficiency on tissue insulin sensitivity would be difficult to predict in the ruminant. Supplemental Cr seems to improve the immune status of stressed J. h i m . Sci. 1994. 72:1591-1599 ruminants MoonsieShageer and Mowat, 1993) . However, in the few studies in which Cr has been fed to non-stressed ruminants, growth and metabolic responses to Cr have been variable (Britton et al., 1968; . In swine, the magnitude of metabolic response to Cr seems to depend on the chemical form of Cr; organic forms seem to be more effective (Page et al., 1993) . The following experiments were conducted specifically to study the effects of Cr on glucose usage and insulin responses in growing calves, using a Cr source (Cr-tripicolinate) that has elicited growth and metabolic responses in nonruminant domestic animals (Page et al., 1993) .
Experimental Procedures

Animals, Diets, and Growth Measures
Ten Holstein steer (Exp. 1 ) and 14 heifer calves (Exp. 2 ) were used in experiments approved by the Institutional Animal Care and Use Committee of the LSU Agricultural Center. Before initiation of each experiment, calves were treated for internal and external parasites (Ivomec, Merck, Rahway, N J ) and vaccinated against infectious bovine rhinotracheitis, parainfluenza-3, and bovine virus diarrhea and with seven-way clostridia. Calves were housed in concretefloored pens in an open-sided barn. In Exp. 1, the calves were grouped by BW into four pens with two pens of larger calves (two calvedpen, 135 f 9 kg initial BW) and two pens of smaller calves (three calvedpen, 80 + 6 kg initial BW). In Exp. 2, the calves were also grouped by BW into four pens with two pens of large calves (three calvedpen; 137 f 5 kg initial BW) and two pens of small calves (four calvedpen; 113 k 4 kg initial BW). In each experiment, one pen of large and one pen of small calves were each randomly assigned to either the control diet or control plus 370 pg of Cr/kg of DM ( CrP) , provided as Cr tripicolinate (12% Cr; Nutrition 21, San Diego, CAI. The basal diets (Table 1 ) contained 526 f 39 pg and 339 f 29 pg of Crkg of DM in Exp. 1 and 2, respectively. To allow for potential rumen losses, the CrP supplementation rate selected was intended to be about two times that suggested as optimum for swine, 200 pg of Cr/kg of DM (Page et al., 1993) . It was also assumed that basal Cr in our diets was probably not in an available form.
Diets were formulated t o promote nearly maximum growth rates in the steers and to support approximately .9 kg ADG in the dairy replacement heifers using NRC (1984) guidelines. Calves had unlimited access to feed and water. Measurements of BW were taken at 0800 on d 16, 30, 44, and 58 of Exp. 1 and on d 14, 28, 42, and 56 of Exp. 2. Calves were deprived of feed and water for 24 h before each weighing.
On d 58 of Exp. 1, all calves were removed from their pens and placed in individual tie stalls, where they were fed in equal increments twice daily at 12-h intervals. Feed intake during this period was restricted to 2.8% of BW (as-fed) to limit feed refusals. On d 71, two steers from each treatment group received glucose and insulin challenges (below). After concluding the challenges, these same steers were placed in metabolism stalls, and feces and urine were collected for 6 d for measuring N balance (Bunting et al., 1989) . On d 80, these steers were returned to the tie stalls and glucose and insulin challenges were performed on the remaining six steers. Nitrogen balance measurements were similarly performed on these calves after concluding the challenges. Immediately following the conclusion of N balance measurements ( d 871, all calves received growth hormone-releasing hormone ( GHRH) challenges (below). In Exp. 2, calves were similarly housed and fed, except that N balance was not measured; also, GHRH challenges ( d 78) and then glucose and insulin challenges ( d 79) were performed on all calves simultaneously.
Blood Collection and Metabolism Challenges
Blood samples were collected via jugular venipuncture immediately after weighing, but before feeding, ' on d 30 and 58 of Exp. 1 and on d 14,28,42, and 58 of Exp. 2. These blood samples were collected into 7-mL evacuated glass tubes with either K3-EDTA (insulin analysis) or NaF and potassium oxalate (all other analyses) included as additives. During metabolic challenges, blood was collected into either 7-mL evacuated tubes with NaF and potassium oxalate (glucose and insulin challenges) or 5-mL, nonevacuated glass tubes containing heparin (GHRH challenge). After collection, blood samples were placed on ice and subsequently centrifuged at 3,000 x g for 10 min at 4°C to obtain plasma.
All challenges were performed after an overnight fast (12 to 16 h ) , and on all challenge days calves received their entire daily allotment of feed as a single feeding after conclusion of the challenge. On the morning of each challenge (approximately 0700), calves were haltered and fitted with indwelling jugular catheters a t such time as to permit the calves at least 1 h of rest before sampling. Catheters were flushed with .5 mL of a sodium citrate solution ( 6 % 1 after sampling. No febrile episodes were observed following the challenges, and calves received 4 x lo6 units of penicillin i.m. at the end of each challenge day.
The i.v. glucose tolerance tests ( IVGTT) consisted of .5 g of glucose/kg of BW infused as a bolus dose over a l-min period. Two hours after the last IVGTT sample was collected, the i.v. insulin challenge test ( M C T ) was initiated. The IVICT consisted of .1 unit of crystalline bovine insulin (25.7 pU/ng; Sigma Chemical, St. Louis, MO) per kilogram of BW infused as a bolus dose over a 10-s period. During IVGTT and IVICT, blood samples were collected at -10, 0, 5, 10, 15, 20, 25, 30, 45, 60, 90, 120, 150 , and 180 min relative to dosing.
Blood samples were collected at 15-min intervals for 6 h before GHRH challenges to establish baseline growth hormone ( GH ) releasing patterns. After GHRH administration (i.v. bolus dose of 1 pg of bovine GHRWkg of BW.75; Sigma), blood samples were again collected at 15-min intervals for 2 h.
Laboratory Analyses
Feed CP (Kjeldahl N) was determined using AOAC ( , and NEFA (NEFA-C kit, Wako Chemicals USA, Richmond, VA). Plasma urea N and plasma insulin were determined as described by Fernandez et al. (1988) . Mean intra-and interassay CV for insulin were 4 and 7%, respectively. Plasma GH was determined by a double-antibody RIA as described by Granger et al. (1989) . The antiserum was generated in our own laboratory against ovine growth hormone, and highly purified bovine growth hormone (USDAbGH-1-1) was used for radioiodination. Sensitivity of the assay averaged .4 ng/mL (based on USDA-bGH-Bl ) , and within-and between-assay coefficients of variation were 8 and 1292, respectively.
Calculations and Statistical Procedures
For each challenge, plasma glucose clearance rate (k) and half-life (ty2) were calculated using the interval between 15 and 30 min (Kaneko, 1989) . Responses of plasma glucose or insulin to IVGTT or IVICT were further evaluated by computing areas under the response curves relative to basal levels using trapezoidal geometry for time periods from 0 to 45 min, 45 to 180 min, and 0 to 180 min after dosing. Concentrations of GH for calves during the 6-h sampling period were subjected to peak analysis using PULSAR (obtained from V. D. Ramirez, Univ. of Illinois, Urbana) as described by Gitzen and Ramirez ( 1976) . Cut-off parameters G(n), for peaks with one through five points, respectively, were set at 5.78, 2.89, 1.90, 1.50, and 1.20.
Growth performance data from Exp. 1 and 2 were pooled and analyzed as a randomized block design. Pen served as the experimental unit, and the model included the effects of block (experiment), treatment, and their interaction, Performance data were pooled after tests for homogeneity of variances indicated that the error mean squares were not different ( P > . l o ) and after determining that there were no ( P > . l o ) treatment x experiment interactions for any performance variable. One steer in the CrP treatment scoured frequently throughout Exp. 1. Data for ADG, blood metabolite concentrations in the periodic blood samples, and responses to IVGTT and IVICT for this steer deviated significantly from that of all other steers. Although performance data for this steer were retained, its metabolic data were not included in the statistical analyses. Also, plasma NEFA and urea N concentrations for one heifer on wk 6 were two and three times, respectively, higher than the average for other heifers, suggesting that she had not been eating normally in the days preceding sampling. A different heifer did not eat normally prior to the challenges and had values for glucose kinetic variables that were about twofold different from the average for the other heifers. Data for these specific measurements for these heifers were excluded as outliers using the criteria described by Mendenhall and Beaver (1991) . Variables for blood metabolite concentrations, glucose and insulin kinetics, and GH criteria were analyzed on an individual animal basis by least squares ANOVA. The model tested the effects of treatment using residual error. All statistical procedures were implemented using the GLM procedures of SAS (1988).
Results
Supplemental CrP did not affect the combined ADG ( P = .74), DMI ( P = .66), or ADGDMI ( P = .18; Table  2 ) of calves in the two experiments. Daily DMI during N balance measurements in Exp. 1 averaged 4.8 kganimal-1.d-1, resulting in an average daily N intake of 118 g per steer. No N balance criteria measured were affected ( P > . l o ) by treatment.
Total plasma cholesterol concentrations were not affected by CrP supplementation in heifers at wk 2 ( P = .66) or wk 4 ( P = .34) or in steers ( P = .34) or heifers ( P = .63) on wk 8 (Table 3) . However, plasma cholesterol concentrations were 26% lower ( P < .05) at wk 4 in steers and 21% lower ( P < .05) at wk 6 in heifers fed CrP than in those fed the control diet. Plasma cholesterol concentrations averaged across wk 2 to 8 were not affected by CrP supplementation in either steers ( P = .19) or heifers ( P = .34). Plasma NEFA concentrations changed little over the course of either experiment, and neither specific sampling period nor average NEFA concentrations were affected ( P > . l o ) by CrP supplementation in either steers or heifers. Although plasma glucose concentrations were relatively constant for both steers and heifers throughout each experiment, plasma insulin concentrations were quite variable across sampling times. Neither specific sampling period nor average plasma concentrations of glucose, creatinine, urea N, total protein, or insulin were affected ( P > .lo) by treatment in either steers or heifers.
Plasma glucose and insulin profiles (Figures 1 and  2 ) suggested that steers and heifers responded similarly to the IVGTT and IVICT. Although basal plasma glucose concentrations were not affected ( P > .lo) by treatment, the rate at which glucose was cleared from the blood during the IVGTT was 40% faster ( P < .05) in steers and 27% faster ( P < .05) in heifers fed CrP than in those fed the control diet (Table 4) . Further, the plasma tm of the glucose load was lower ( P < .05) for both steer and heifer calves fed CrP than for those fed the control diet. Also, the area under the response curve ( AUC) for glucose from 0 to 180 min after dosing was lower ( P < . 0 5 ) for steers fed CrP than for those fed the control diet.
Inclusion of CrP in the diet had no effect ( P > . l o ) on basal plasma insulin concentrations or the AUC for plasma insulin from 0 to 180 min after dosing in either steers or heifers.
Because the IVICT followed the last sampling for the IVGTT by only 2 h, the higher ( P < .05) basal Table   concentrations of glucose in the control than in the CrP-fed steers may have represented a small amount of glucose carryover from the IVGTT. This effect was not observed ( P = .62) in the heifers. During IVICT, the rate at which glucose was cleared from the blood tended ( P = .12> to be faster and plasma glucose t1/2 tended ( P = .15) to be shorter in steers fed CrP than in those fed the control diet. Similarly, the rate at which glucose was cleared from the blood was 44% faster ( P < .05) and plasma glucose t l / 2 was 30% lower ( P < .05) in heifers fed CrP than in those fed the control diet. Plasma glucose concentrations following IVICT seemed to return to baseline concentrations more rapidly in steers and heifers fed CrP than in 3. Chromium picolinate (CrP) effects on pre-feeding plasma cholesterol on weeks 2 to 8 and average concentrationsa of those plasma measurements not affected by CrP in steer (Exp. control-fed calves (Figure 2 ). This pattern seemed to be confirmed by AUC analysis for glucose. Although AUC from 0 to 45 min after dosing was similar for control and CrP-fed steers ( P = .94) and heifers ( P = .66), AUC from 45 t o 180 min after dosing was 19% higher ( P = .14) for steers and 25% higher ( P < .05) for heifers fed CrP than for those fed the control diet. The AUC from 0 to 180 min after dosing was not affected ( P = .2 1) by treatment in steers but tended ( P = .11) to be lower for heifers fed CrP than for control-fed heifers. None of the insulin kinetic criteria measured in response to the IVICT were influenced ( P > . l o ) by inclusion of CrP in the diet.
Although CrP inexplicably increased ( P < . l o ) the number of GH peaks during the 6-h sampling period in both steers and heifers, all other indices of GH secretion were generally not affected ( P 7 . l o ) by CrP (Table 5) . In both experiments, AUC and GH peak amplitude in response to a GHRH challenge were similar for calves fed either CrP or the control diets. 
Discussion
There is increasing evidence that supplemental Cr may have multiple health and nutritional benefits for domestic livestock. Generally, positive responses seem to be related either t o improved immunocompetence and stress resistance or to an apparent shifting of energy deposition from adipose to lean tissues. In ruminants, positive responses in feed intake and growth seem to have been exclusively limited to improvements in immunocompetence. When high-Cr yeast or chelated Cr was fed to "market-transit" stressed feeder calves, reduced morbidity and improvements in most growth performance criteria were observed during the first few weeks after arrival Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993) . Improved health and growth performance were invariably associated with improvements in stress and(or) immune criteria. aKinetic criteria: basal glucose or insulin concentrations immediately prior to challenges; glucose or insulin clearance rates and half-life computed from 15 to 30 min after challenge. bTreatment effect ( P < .05) for steers. 'Treatment effect ( P < ,051 for heifers.
Ia contrast, when physiologically adapted calves were fed over longer feeding periods, growth performance was not affected by Cr supplementation . The growth performance of calves in our study was similarly not affected by supplemental CrP (Table 2) . It should be noted that both of these experiments were conducted during our most moderate seasons (winter and spring) and calves showed little evidence of physiological stress.
Supplementation with Cr has resulted in positive but variable increases in the growth rate of nonstressed nonruminants (Steele and Rosebrough, 1979; Page et al., 1993) . These responses are likely attributable to the apparent effect of Cr on the distribution of energy between adipose and lean tissue. Chromium picolinate has been reported t o increase both lean body mass and body fat loss in weight-training men (Evans, 1989) . In addition, 200 pgkg of Cr as CrP has been shown t o have generally favorable effects on muscling and fat indices of growing-finishing swine (Page et al., 1993) . Although there is evidence that organic forms of Cr may be more effective in altering body composition (Page et al., 19931, Anderson et al. (1989) reported that supplemental Cr as CrC13 increased the percentage of turkey breast. In ruminants, the effects of Cr on energy deposition are not clear. Although CrP has reduced indices of fatness in lambs (Kitchalong et al., 19931, Chang et al. (1992) reported that carcass characteristics of steers fed a high-Cr yeast for 138 d were not changed.
Body composition could be altered by a proportional increase in net protein synthesis and(or) by a reduction in lipogenesis. As noted by Page et al.
(19931, Cr could alter protein deposition through its known involvement with AA incorporation and utilization and synthesis of nuclear protein and RNA. In our study, N balance was not affected by supplemental CrP (Table 21 , suggesting that CrP had little influence on the efficiency of protein deposition. In contrast, Britton et al. (1968) found that only 37 pg of Cr daily as CrC13 increased N retention in lambs.
There is indirect evidence that supplemental Cr may alter lipid metabolism, because circulating lipids are often reduced when the diet is supplemented with Cr (Riales and Albrink, 1981; Mertz, 1993) . OFlaherty and McCarty ( 19 78 1 reported decreased release of NEFA from the adipose tissue of rats receiving Crsupplemented diets. Although plasma cholesterol was variably reduced, NEFA concentrations changed little over the course of either of our experiments (Table 3 ) . In nonruminant animals supplemented with Cr, reduced serum total cholesterol concentration is among the most frequently reported responses in lipid metabolism (Mertz, 1993) . In studies with ruminants, serum total cholesterol has often not responded to supplemental Cr (Samsell and Spears, 1989; . However, Samsell (1987) observed that serum total cholesterol concentrations seemed to increase in lambs over the course of that 102-d experiment. Cholesterol concentrations seemed to increase more slowly in lambs supplemented with Cr, such that concentrations tended to become different by d 56. Although serum NEFA were not affected by Cr in that study, Samsell and Spears (1989) did observe trends for reduced serum NEFA in lambs supplemented with CrC13 when fed high-fiber, but not low-fiber, diets. To our knowledge, the mechanism of action of Cr on lipid metabolism is not understood. Mertz (1993) suggested that the more dramatic hypolipidemic effects of organic Cr in humans may be attributable simply to improved glucose tolerance. However, it is not clear whether subtle changes in the glucose tolerance of normal, producing ruminants would be sufficient to produce measurable changes in circulating lipid concentrations.
Among the specific effects of growth hormone are increased rate of protein synthesis and increased mobilization of fatty acids from adipose tissue (Guyton, 1991) . Most indices of GH secretion measured in this study were not affected by CrP (Table 5 ) . Although indices of muscling were generally increased in their study, Page et al. (1993) also observed that circulating concentrations of GH were not changed by CrP in swine. Taken together, these findings may indicate that any potential effects of CrP on growth or body composition are probably not being exerted through an increase in GH secretion.
Plasma glucose concentrations following IVICT seemed to return to baseline concentrations more rapidly in steers and heifers fed CrP than in those fed the control diet (Figure 2 ) . Although some indirect effect of CrP on glucose production cannot be ruled out, this effect is likely an artifact of the inertial effects of the glucose counter-regulatory hormones in response to the more drastic reduction in plasma glucose in calves fed CrP.
The previous points notwithstanding, IVGTT and IVICT data (Table 4) suggest that the primary effect of CrP on carbohydrate metabolism was to increase the response of the calves' tissues to insulin. Ruminants derive most of their glucose requirement from hepatic gluconeogenesis rather than from intestinal absorption, and their tissues seem to be more refractory to insulin than the tissues of nonruminants (Brockman, 1986) . However, the significance of enhanced insulin responsiveness in the ruminant in relation t o the net synthesis of fat and protein may be dificult to predict. Insulin seems to have little anabolic effect on muscle tissue of growing ruminants (Lobley, 1993) , and it has been suggested that ruminant adiDose tissue may be more efficient in Brockman, R. P. 1993 . Glucose and short-chain fatty acid metaboextracting blood glucose than muscle tissue (Brockman, 1993) . Therefore, it could be argued that increased insulin sensitivity could make the growingfinishing ruminant fatter. Subiyatno et al. (1993a) reported that supplementing with 500 pgkg of organic Cr, beginning 6 wk prepartum and continuing through early lactation, increased milk production by 13% in primiparous cows and had little effect on multiparous cows. In these same cows (Subiyatno et al., 1993b1 , glucose kinetics criteria during pre-and postpartum IVGTT were largely not affected by supplemental Cr; however, prepartum insulin resistance seemed to be reduced in the primiparous cows. In contrast to these studies, Samsell (1987) reported that glucose clearance during IVGTT was not altered by inclusion of CrC13 in the diet. Similarly, Samsell and Spears ( 1989) observed that clearance of a n intraperitoneal dose of glucose was not changed in lambs fed supplemental CrC13. This may indicate that a n organic form of Cr may be required for adequate intestinal absorption a n d ( o r ) incorporation of Cr into a n insulin receptor-glucose tolerance complex.
Implications
The results of these experiments suggest that supplemental chromium, as chromium picolinate, enhances the response of calf tissues to insulin. Furthermore, reduced plasma cholesterol concentrations may indicate that lipid metabolism is altered in calves fed diets containing chromium picolinate. Although linear growth rate and N retention were not improved in these experiments, metabolic data imply that tissue assimilation of nutrients could be altered by supplemental chromium picolinate. Feeding studies of longer duration that culminate with carcass evaluation are needed to ascertain whether chromium picolinate may change the body composition of ruminants in the manner that has been observed in humans and swine.
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